Upregulation of TGF-β is associated with reduced granule exocytosis, tumor-killing activity, and IFN-γ secretion of NK cells by down-regulating their activating receptors, including NKG2D, NKp30, and DNAM-1 (105). The gene discussed is TGFB1; the disease is neoplasm.